Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.
Novavax’ clinical development program reported no severe allergic reactions
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
MedTel aims to raise series A for rapid business expansion, product improvement & conducting relevant clinical validation studies.
Plant is part of the company's CAD $30 million capital investment in the site
The Bill aims to amend and consolidate the law relating to the import, manufacture, distribution and sale of drugs, medical devices and cosmetics
Domestic devices are usually preferred over imported medical devices in the national or regional procurement.
These medicines have low risk of hypoglycemia, provide beta cell protection, offer cardio-renal benefits and are safe for patients with kidney or liver conditions and senior citizens
Fermentation-based manufacturing leverages Evonik’s biotechnology platform
Subscribe To Our Newsletter & Stay Updated
